HLA alloimmunization in patients requiring ventricular assist device support
- 1 November 2002
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (11) , 1218-1224
- https://doi.org/10.1016/s1053-2498(02)00448-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- LVAD treated heart recipients do not have deleterious HLA antibody.The Journal of Heart and Lung Transplantation, 2001
- Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant RecipientsAnnals of Surgery, 2000
- Immunobiology of left ventricular assist devicesProgress in Cardiovascular Diseases, 2000
- Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de viceThe Lancet, 1999
- Factors Influencing HLA Sensitization in Implantable LVAD RecipientsThe Annals of Thoracic Surgery, 1997
- Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to TransplantationCirculation, 1997
- Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?The Journal of Thoracic and Cardiovascular Surgery, 1996
- Implantable LVAD infections: Implications for permanent use of the deviceThe Annals of Thoracic Surgery, 1996
- Fungal Infections in Left Ventricular Assist Device RecipientsAsaio Journal, 1995
- A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemiaBlood, 1983